{"SPADE_UN_29657": {"Sequence Information": {"Peptide Name": "DP4, HH2 [Q2C,L3W]", "Sequence": "VCWRIRVAVIRA", "Sequence Length": 12, "Biological Activity": ["Anti-Gram+", "Anti-Gram-"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method.", "Pubmed ID": "24982064", "Reference": "Antimicrob Agents Chemother. 2014;58:5342-5349", "Author": "Wu X, Wang Z, Li X, Fan Y, He G, Wan Y, Yu C, Tang J, Li M, Zhang X, Zhang H, Xiang R, Pan Y, Liu Y, Lu L, Yang L", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/24982064"}], "Mass": 1441.79, "PI": 11.7, "Net Charge": 3, "Hydrophobicity": 1.11, "Frequent Amino Acids": "RVA", "Absent Amino Acids": "DEFGHKLMNOPQSTUY", "Basic Residues": 3, "Acidic Residues": 0, "Hydrophobic Residues": 8, "Polar Residues": 4, "Positive Residues": 3, "Negative Residues": 0, "SPADE ID": "SPADE_UN_29657", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_29657", "Similarity": 1.0, "Sequence": "VCWRIRVAVIRA"}, {"SPADE_ID": "SPADE_UN_05949", "Similarity": 1.0, "Sequence": "RIRVAV"}, {"SPADE_ID": "SPADE_UN_00462", "Similarity": 0.9166666666666666, "Sequence": "VRWRIRVAVIRA"}], "Hemolytic Activity": "", "Target Organism": "Staphylococcus aureus ATCC 25923(MIC=32µg/ml),Escherichia coli ATCC 25922(MIC=64µg/ml),Pseudomonas aeruginosa PAO1(MIC=64µg/ml),Salmonella enterica serovar Typhimurium(MIC=64µg/ml)"}}}